Clinical Trials on CD19-positive
Total 5815 results
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial HospitalNot yet recruitingCD19-positive Relapsed or Refractory B-cell MalignanciesChina
-
The Second Affiliated Hospital of Henan University...First Affiliated Hospital of Wenzhou Medical University; Second Affiliated... and other collaboratorsUnknown
-
Bambino Gesù Hospital and Research InstituteActive, not recruitingCD19-ALL | CD19-LNHItaly
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
PETHEMA FoundationTerminatedPhiladelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALLSpain
-
Hrain Biotechnology Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingAcute Lymphoblastic Leukemia | CD19-positiveChina
-
Shanghai Unicar-Therapy Bio-medicine Technology...The First Affiliated Hospital of Soochow UniversityRecruitingAcute Lymphoblastic Leukemia | Relapse | CD19 Positive | RefractoryChina
-
RenJi HospitalCARsgen Therapeutics Co., Ltd.UnknownCD19 Positive Malignant B-cell Leukemia and LymphomaChina
-
Crystal Mackall, MDCalifornia Institute for Regenerative Medicine (CIRM)Active, not recruitingB Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Minimal Residual Disease | CD19 PositiveUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingPhiladelphia Chromosome Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD19 PositiveUnited States
-
Xijing HospitalXi'An Yufan Biotechnology Co.,LtdRecruitingLymphoma, B-Cell | CD19 Positive | Leukemia Lymphocytic Acute (ALL) in Relapse | Leukemia Lymphocytic Acute (All) RefractoryChina
-
University College, LondonCompletedCD19+ Malignancies: Relapse Post-allogeneic TransplantUnited Kingdom
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.UnknownCD19+ Lymphoma, B-Cell | CD19+ Leukemia, B-CellChina
-
Seattle Children's HospitalActive, not recruitingCD19+ Acute LeukemiaUnited States
-
Precision BioSciences, Inc.RecruitingHematologic Malignancy | CD19 Expressing MalignanciesUnited States
-
Shenzhen Geno-Immune Medical InstituteThe Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children... and other collaboratorsRecruiting
-
Fujian Medical UniversityRecruitingRelapsed or Refractory DLBCL Patients With Either CD19 or CD20 PositiveChina
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingFollicular Lymphoma | Diffuse Large B-cell Lymphoma | CD19-positiveChina
-
Chinese PLA General HospitalRecruitingCD19+ Relapse/Refractory B-ALLChina
-
Crystal Mackall, MDRecruitingRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Refractory Acute Lymphoblastic Leukemia | Minimal Residual Disease | CD19 PositiveUnited States
-
Institute of Hematology & Blood Diseases Hospital...Suzhou Fundamenta TherapeuticsRecruitingAutoimmune Hemolytic Anemia | CD19 CAR-T Cell InfusionChina
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei HospitalRecruitingCD19+ and CD 22+ B-ALLChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30China
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
Mayo ClinicTerminatedResilience, Psychological | Psychology, Positive | Positive ThinkingUnited States
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR)CompletedSustained Positive Emotions | Sustained Positive Behavior ChangeUnited States
-
University of Illinois at ChicagoWithdrawnKidney Transplant Rejection | Positive FCXM (T or B Cell Positive) | Positive CDC Cross-Match (B Cell Positive) | Kidney/Pancreas Transplant RejectionUnited States
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
Seoul National University HospitalRecruitingVery High Risk Acute Lymphoblastic Leukemia | CD19 CAR-T TherapyKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
Institute of Hematology & Blood Diseases Hospital...Juventas Cell Therapy Ltd.RecruitingAutoimmune Hemolytic Anemia | Autologous CD19 CAR-T | Failure of Three or More Lines of TherapyChina
-
Chinese PLA General HospitalUnknownRelapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACIChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Universidade Federal do Rio Grande do NorteUniversidade Estadual da ParaibaRecruitingContinuous Positive Airway Pressure | Cardiac Surgical Procedures | BIPAP Biphasic Intermittent Positive Airway PressureBrazil
-
Carisma Therapeutics IncRecruiting
-
Shanghai Longyao Biotechnology Inc., Ltd.UnknownThe Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)B-cell Acute Lymphoblastic Leukemia (B-ALL) | Safety and Efficacy of CD19 UCAR-T CellsChina
-
The University of Texas Health Science Center,...Completed
-
Han weidongRecruitingRelapsed and Refractory B-cell Non-Hodgkin's Lymphoma | Decitabine-primed Tandem CD19/CD20 CAR T CellsChina
-
Tongji HospitalRecruiting
-
First Affiliated Hospital of Harbin Medical UniversityUnknownCD19-chimeric Antigen Receptor T Cells | Relapsed and/or Refractory Acute Lymphoblastic Leukemia | the Haploidentical Hematopoietic Stem Cell TransplantationChina
-
Betta Pharmaceuticals Co., Ltd.Unknown
-
Eisai Co., Ltd.Completed
-
The First Affiliated Hospital of Xiamen UniversityRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCLDN18.2 Positive Solid TumorsChina
-
Fudan UniversityCompletedPositive End Expiratory PressureChina
-
Addario Lung Cancer Medical InstituteCompletedALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive TumorsROS1-fusion Positive TumorUnited States